CD8+ T-cells in psoriatic lesions preferentially use T-cell receptors V beta 3 and/or V beta 13.1 genes.

J C Chang; L R Smith; K J Froning; B J Schwabe; J A Laxer; L L Caralli; H H Kurkland; M A Karasek; D I Wilkinson; D J Carlo

doi:10.1111/j.1749-6632.1995.tb44541.x

CD8+ T-cells in psoriatic lesions preferentially use T-cell receptors V beta 3 and/or V beta 13.1 genes.

Identifier:nobleid.org/w1/20260515/28BC9290

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/28BC9290.svg?ark=w1%2F20260515%2F28BC9290)](https://nobleid.org/work/w1/20260515/28BC9290)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

CD8+ T-cells in psoriatic lesions preferentially use T-cell receptors V beta 3 and/or V beta 13.1 genes.

Identifier:nobleid.org/w1/20260515/28BC9290

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/28BC9290.svg?ark=w1%2F20260515%2F28BC9290)](https://nobleid.org/work/w1/20260515/28BC9290)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work